Table of contents

Volume 97, Issue 10
Published online 13 November 2007 (1329-1464)

Top

Clinical Studies

Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients FREE

J Atzpodien, K Terfloth, M Fluck and M Reitz

Br J Cancer 97: 1329-1332; advance online publication, October 30, 2007; doi:10.1038/sj.bjc.6604045

Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer FREE

I Craven, A Crellin, R Cooper, A Melcher, P Byrne and D Sebag-Montefiore

Br J Cancer 97: 1333-1337; advance online publication, November 6, 2007; doi:10.1038/sj.bjc.6604042

A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours FREE

G Attard, J Kitzen, S P Blagden, P C Fong, L C Pronk, J Zhi, G Zugmaier, J Verweij, J S de Bono and M de Jonge

Br J Cancer 97: 1338-1343; doi:10.1038/sj.bjc.6604043

Top

Translational Therapeutics

R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies FREE

J Arts, P Angibaud, A Mariën, W Floren, B Janssens, P King, J van Dun, L Janssen, T Geerts, R W Tuman, D L Johnson, L Andries, M Jung, M Janicot and K van Emelen

Br J Cancer 97: 1344-1353; doi:10.1038/sj.bjc.6604025

Combinatorial experimental protocols for Erbicin-derived immunoagents and Herceptin FREE

C De Lorenzo, F Troise, V Cafaro and G D'Alessio

Br J Cancer 97: 1354-1360; advance online publication, October 9, 2007; doi:10.1038/sj.bjc.6604022

Profilin-1 is a negative regulator of mammary carcinoma aggressiveness FREE

L Zou, M Jaramillo, D Whaley, A Wells, V Panchapakesa, T Das and P Roy

Br J Cancer 97: 1361-1371; advance online publication, October 16, 2007; doi:10.1038/sj.bjc.6604038

Purinergic regulation of angiogenesis by human breast carcinoma-secreted nucleoside diphosphate kinase FREE

S M Rumjahn, M A Javed, N Wong, W E Law and I L O Buxton

Br J Cancer 97: 1372-1380; advance online publication, October 16, 2007; doi:10.1038/sj.bjc.6604019

Photodynamic therapy-generated vaccines: relevance of tumour cell death expression FREE

M Korbelik, B Stott and J Sun

Br J Cancer 97: 1381-1387; advance online publication, October 30, 2007; doi:10.1038/sj.bjc.6604059

Top

Molecular Diagnostics

Cyclooxygenase-2 overexpression abrogates the antiproliferative effects of TGF-beta  FREE

G A Enders

Br J Cancer 97: 1388-1392; advance online publication, October 23, 2007; doi:10.1038/sj.bjc.6604048

The validity of the Royal College of Pathologists' colorectal cancer minimum dataset within a population FREE

N J Maughan, E Morris, D Forman and P Quirke

Br J Cancer 97: 1393-1398; advance online publication, October 16, 2007; doi:10.1038/sj.bjc.6604036

Circulating cell-free DNA as a predictive marker for distant metastasis of hepatitis C virus-related hepatocellular carcinoma FREE

Y Tokuhisa, N Iizuka, I Sakaida, T Moribe, N Fujita, T Miura, S Tamatsukuri, H Ishitsuka, K Uchida, S Terai, K Sakamoto, T Tamesa and M Oka

Br J Cancer 97: 1399-1403; advance online publication, October 16, 2007; doi:10.1038/sj.bjc.6604034

The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus FREE

M Sarbia, N Ott, F Pühringer-Oppermann and B L D M Brücher

Br J Cancer 97: 1404-1408; advance online publication, October 16, 2007; doi:10.1038/sj.bjc.6604037

Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma FREE

H-F Yuen, Y-P Chan, K-K Chan, Y-Y Chu, M L-Y Wong, S Y-K Law, G Srivastava, Y-C Wong, X Wang and K-W Chan

Br J Cancer 97: 1409-1415; doi:10.1038/sj.bjc.6604035

Top

Genetics and Genomics

Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumours FREE

H Carén, S Fransson, K Ejeskär, P Kogner and T Martinsson

Br J Cancer 97: 1416-1424; advance online publication, October 16, 2007; doi:10.1038/sj.bjc.6604032

Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features FREE

K Harada, S Hiraoka, J Kato, J Horii, H Fujita, K Sakaguchi and Y Shiratori

Br J Cancer 97: 1425-1431; advance online publication, October 9, 2007; doi:10.1038/sj.bjc.6604014

Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model FREE

M Niedergethmann, F Alves, J K Neff, B Heidrich, N Aramin, L Li, C Pilarsky, R Grützmann, H Allgayer, S Post and N Gretz

Br J Cancer 97: 1432-1440; advance online publication, October 16, 2007; doi:10.1038/sj.bjc.6604031

Identification of aberrant forms of alkaline sphingomyelinase (NPP7) associated with human liver tumorigenesis FREE

Y Cheng, J Wu, E Hertervig, S Lindgren, D Duan, Å Nilsson and R-D Duan

Br J Cancer 97: 1441-1448; advance online publication, October 9, 2007; doi:10.1038/sj.bjc.6604013

Thymidylate synthase polymorphisms, folate and B-vitamin intake, and risk of colorectal adenoma FREE

R A Hubner, J-F Liu, G S Sellick, R F A Logan, R S Houlston and K R Muir

Br J Cancer 97: 1449-1456; advance online publication, October 30, 2007; doi:10.1038/sj.bjc.6604056

Sequential gene promoter methylation during HPV-induced cervical carcinogenesis FREE

F E Henken, S M Wilting, R M Overmeer, J G I van Rietschoten, A O H Nygren, A Errami, J P Schouten, C J L M Meijer, P J F Snijders and R D M Steenbergen

Br J Cancer 97: 1457-1464; advance online publication, October 30, 2007; doi:10.1038/sj.bjc.6604055

The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.

Extra navigation

ADVERTISEMENT

naturejobs